-
Detailed Description
CAS Number: 75330-75-5
Molecular Formula: C24H36O5
Molecular Weight: 404.54
Mechanism of Action: Lovastatin is an inhibitor of 3-hydroxy-3methylglutaryl-coenzyme A reductase (HMG-CoA reductase), an enzyme that catalyzes the conversion of HMG-CoA to mevalonate
Storage Conditions: 2-8°C
Tariff Code: 2932.20.5050
-
Applications
Cancer Applications: Research has shown that statin drugs including lovastatin have been able to inhibit melanoma cell growth when high concentrations are used.
-
Specifications
Form: Powder
Appearance: White crystalline powder
Source: Monascus Ruber
Assay: 98.5-101.0%
Loss on Drying: ≤0.3%
Optical Rotation: +234° to +338°
Purity Level: ≥95.0%
-
Technical Data
Solubility: Water: 0.4 µg/mL
Impurity Profile: Chloride
And stuff -
References
References:
Eustace, A. J., and et al. "The 3-hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors, Simvastatin, Lovastatin and Mevastatin Inhibit Proliferation and Invasion of Melanoma Cells." BMC Cancer 8.9 (2008): www.ncbi.gov. 16 Jan. 2008. Web. 31 Aug. 2012.
Lovastatin is a statin prodrug commonly used to combat hypercholesterolemia. Lovastatin inhibits HMG-CoA reductase, a significant enzyme involved in the cholesterol synthesis pathway. Lovastatin is insoluble in aqueous solution.
CAS Number: 75330-75-5
Molecular Formula: C24H36O5
Molecular Weight: 404.54
Mechanism of Action: Lovastatin is an inhibitor of 3-hydroxy-3methylglutaryl-coenzyme A reductase (HMG-CoA reductase), an enzyme that catalyzes the conversion of HMG-CoA to mevalonate
Storage Conditions: 2-8°C
Tariff Code: 2932.20.5050
Cancer Applications: Research has shown that statin drugs including lovastatin have been able to inhibit melanoma cell growth when high concentrations are used.
Form: Powder
Appearance: White crystalline powder
Source: Monascus Ruber
Assay: 98.5-101.0%
Loss on Drying: ≤0.3%
Optical Rotation: +234° to +338°
Purity Level: ≥95.0%
Solubility: Water: 0.4 µg/mL
Impurity Profile: Chloride
And stuff
References:
Eustace, A. J., and et al. "The 3-hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors, Simvastatin, Lovastatin and Mevastatin Inhibit Proliferation and Invasion of Melanoma Cells." BMC Cancer 8.9 (2008): www.ncbi.gov. 16 Jan. 2008. Web. 31 Aug. 2012.